| PERIOD ENDING | 30-Jun-04 | 31-Mar-04 | 31-Dec-03 | 30-Sep-03 | | Total Revenue | 1,179 | 987 | 55 | 471 | | Cost of Revenue | 1,072 | 822 | (61) | 219 | | | Gross Profit | 107 | 165 | 116 | 252 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,999 | 5,899 | 2,137 | 2,506 | | Non Recurring | 105 |
-
|
-
|
-
| | Others |
-
|
-
|
-
| (1) | | | | Total Operating Expenses | 2,104 | 5,899 | 2,137 | 2,505 | | | | Operating Income or Loss | (1,997) | (5,734) | (2,021) | (2,253) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (14) | (563) | (99) | (166) | | Earnings Before Interest And Taxes | (2,011) | (6,297) | (2,120) | (2,419) | | Interest Expense | 9 | 16 | 21 | 12 | | Income Before Tax | (2,020) | (6,313) | (2,140) | (2,430) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,020) | (6,313) | (2,140) | (2,430) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,020) | (6,313) | (2,140) | (2,430) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,020) | ($6,313) | ($2,140) | ($2,430) |
|
0.83% Nasdaq 
Income Statement
